(1 - 9 from 9
)
Special Seminar by David Klatzmann Jensen with title, “The Promises...
www.bioacademy.gr
SPECIAL SEMINAR “The Promises of low-dose IL-2 for Autoimmune and Inflammatory Diseases” Thursday November 26th :00-12:00 Γ1 3rd floor seminar room...
Servier Gains Option for Iltoo Autoimmune Disease Candidate
www.genengnews.com
Paris-based Iltoo seeks to commercialize research by its co-founder, David Klatzmann, M.D., Ph.D., and his team of researchers from Paris ...
sorted by relevance / date